Document Detail


Circulating neuregulin during the transition from stage a to stage b/c heart failure in a breast cancer cohort.
MedLine Citation:
PMID:  23273589     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: Breast cancer (BC) treatments can cause heart failure (HF) in a subset of patients. ACC/AHA guidelines classify patients receiving cardiotoxic medications as stage A, a high-risk population for the development of HF. Circulating neuregulin (NRG) correlates with outcomes in stage C and D HF. We examined the levels of NRG in a BC cohort receiving cardiotoxic chemotherapy and its relationship with adverse cardiac effects during the transition from stage A to stage B or C HF.
METHODS AND RESULTS: In an ongoing prospective study, a planned interim analysis of 78 BC women receiving either anthracycline (AC) or trastuzumab (Tsz) was performed. Biometric data, cardiac risk factors, and NRG levels, were collected before chemotherapy and after completion of AC therapy and/or 3 months into Tsz therapy. Cardiac function was measured by left ventricular ejection fraction (LVEF) by echocardiography at the above time points and longitudinally as standard of care. The interim cohort was predominately white with stage II BC and a median age of 50 years. A reduction of >10 absolute percentage points in LVEF was observed in 21.4% of the cohort, representing a transition from stage A to stage B or C HF. A statistically significant drop in plasma NRG was observed in women treated with AC and/or Tsz (P < .001). Additionally, baseline NRG correlated with the maximal change in LVEF.
CONCLUSIONS: More than 20% of women experienced cardiac dysfunction, detected by decline in LVEF, and were reclassified as stage B or C HF. Plasma NRG levels were reduced after exposure to cardiotoxic chemotherapy, suggesting a loss in a cardioprotective growth factor. Higher baseline NRG levels were observed in those with the greatest decline in LVEF, supporting the continued investigation of NRG as a potential prognostic marker in early-stage HF.
Authors:
Carrie A Geisberg; Wissam M Abdallah; Monica da Silva; Cheri Silverstein; Holly M Smith; Vandana Abramson; Ingrid Mayer; Julie Means-Powell; Darla Freehardt; Brenda White; Daniel Lenihan; Douglas B Sawyer
Related Documents :
11712789 - A new staging system based on tumor volume in gastric cancer.
23250819 - Validation of the risk model: high-risk classification and tumor pattern of invasion pr...
18705299 - Circular tumor growth: a prognostic factor in stage ii colorectal carcinoma.
10053109 - Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observat...
3193769 - Primary carcinoma of the gallbladder: tnm staging and prognosis.
23639619 - Clinical trial participation and outcome for patients with glioblastoma: multivariate a...
15380569 - Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced hea...
17335599 - The isolated gamma probe technique for sentinel node penile carcinoma detection is unre...
14662119 - Possible contribution of circulating interleukin-10 (il-10) to anti-tumor immunity and ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiac failure     Volume:  19     ISSN:  1532-8414     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  10-5     Citation Subset:  IM    
Copyright Information:
Published by Elsevier Inc.
Affiliation:
Division of Cardiovascular Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; Division of Cardiovascular Medicine, University of Louisville School of Medicine, Louisville, Kentucky. Electronic address: carrie.geisberg@vanderbilt.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Randomized Controlled Pilot Study of Outcomes of Strict Allowance of Fluid Therapy in Hyponatremic...
Next Document:  Postoperative Right Ventricular Failure After Left Ventricular Assist Device Placement is Predicted ...